Drew Hannaman | Vice President of Research and Development
Ichor Medical Systems

Drew Hannaman, Vice President of Research and Development, Ichor Medical Systems

Drew Hannaman has served as the Vice President of Research & Development at Ichor Medical Systems since 2000. In that role he has been responsible for the development of the company's electroporation based TriGrid Delivery System for DNA vaccine administration. The technology has been incorporated into more than 20 clinical stage products addressing a range of disease indications.  He is a co-author of over 40 publications in the field of DNA based biologics. He holds a degree in Cybernetics from the University of California, Los Angeles and has over twenty years of experience in the development of drug delivery systems.

Appearances:



Agenda Day 2 @ 4:00

Electroporation mediated DNA immunization: Clinical progress and technology development

  • Review of clinical experience with electroporation based intradermal and intramuscular DNA vaccination
  • Development of electroporation device technology to support the development & deployment of novel DNA vaccine candidates
  • Adaptation of electroporation for delivery of DNA encoding monoclonal antibodies

back to speakers